ROCKWELL MEDICAL, INC. (RMTI) › Cost of RevenueROCKWELL MEDICAL, INC. (RMTI) — Cost of RevenueAnnual figures by fiscal year, from SEC filings.2017: $53.60M2018: $64.97M2019: $58.46M2020: $59.47M2021: $64.35M2022: $68.73M2023: $74.91M2024: $84.00M2025: $57.56M$57.56M2017Cost of Revenue (USD)2025Fiscal YearCost of RevenueChange YoY2025$57.56M-31.5%2024$84.00M+12.1%2023$74.91M+9.0%2022$68.73M+6.8%2021$64.35M+8.2%2020$59.47M+1.7%2019$58.46M-10.0%2018$64.97M+21.2%2017$53.60M—Other metrics: RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share